Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal

References

Page 1

	Year	Citations
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding Ravi Sarode, Truman J. Milling, Majed A. Refaai, Circulation	2013	778
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial Joshua N. Goldstein, Majed A. Refaai, Truman J. Milling, The Lancet ThrombosisCardiovascular DiseaseRandomised TrialHematologySurgery	2015	444
Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: An open, prospective randomized controlled trial Lonneke van Aart, H.W. Eijkhout, Jan S. Kamphuis, Thrombosis Research ThrombosisVenous ThrombosisCardiovascular DiseaseOral Anticoagulant TherapyMedicine	2005	159
An update of consensus guidelines for warfarin reversal Huyen Tran, Sanjeev Chunilal, Paul Harper, The Medical Journal of Australia Warfarin ReversalPharmacotherapyThrombosisVenous ThrombosisStroke	2013	157
Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation Masahiro Yasaka, Toshiyuki Sakata, Hiroaki Naritomi, Thrombosis Research ThrombosisVenous ThrombosisOptimal DoseHematologyHemostasis	2004	144
Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies Truman J. Milling, Majed A. Refaai, Joshua N. Goldstein, Annals of Emergency Medicine	2015	85
An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies Nakisa Khorsand, Nic J.G.M. Veeger, Reinier M. van Hest, Haematologica	2012	67
Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy Nakisa Khorsand, Nic J.G.M. Veeger, M. C. A. Müller, Transfusion Medicine	2010	58
The effectiveness and safety of fixed low‐dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin (CME) Cindy Varga, Sultan Altouri, Stella Papadoukakis, Transfusion ThrombosisCardiovascular DiseaseHematologyClinical EpidemiologyWarfarin Therapy	2012	37
Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy Pritesh Junagade, R. Grace, Pamela Gover Hematology ThrombosisVenous ThrombosisIdeal DoseCardiovascular DiseaseBlood Platelet	2007	19

Page 1